Incyte Corp (INCY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-1993 | 12-1992 | 12-1991 | |
| Sales | 279 | 1,635 | 336 |
| Gross Profit | 279 | 1,635 | 336 |
| Operating Expenses | 5,231 | 3,794 | 1,843 |
| Operating Income | -4,952 | -2,159 | -1,507 |
| Interest Expense | 109 | 32 | 0 |
| Other Income | 169 | 65 | 53 |
| Pre-tax Income | -4,892 | -2,126 | -1,454 |
| Net Income Continuous | -4,892 | -2,126 | -1,454 |
| Net Income | $-4,892 | $-2,126 | $-1,454 |
| EPS Basic Total Ops | -0.57 | N/A | N/A |
| EPS Basic Continuous Ops | -0.19 | N/A | N/A |
| EPS Diluted Total Ops | -0.57 | N/A | N/A |
| EPS Diluted Continuous Ops | -0.19 | N/A | N/A |
| EBITDA(a) | $-4,516 | $-1,952 | $-1,451 |